SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
Insel Gruppe AG, University Hospital Bern
80 participants
Jan 3, 2023
INTERVENTIONAL
Conditions
Summary
With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Experiment will be performed without dopaminergic medication
Turning off the stimulation during experiment
Experiment will be performed with dopaminergic medication
Experiment will be performed with stimulation (ON condition)
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05765110